Today: 13 May 2026
Micron Stock Today: AI Memory Bounce Meets China Trade Hope and a Crowded Chart
13 May 2026
3 mins read

Micron Stock Today: AI Memory Bounce Meets China Trade Hope and a Crowded Chart

New York, May 13, 2026, 06:38 (ET)

  • Micron shares were quoted around $812 before the bell, rising 5.93%. On Tuesday, the stock dropped 3.61%. According to Reuters, memory-chip makers spearheaded the chip sector’s rebound.
  • This uptick tracks buyers snapping up chips, BofA’s renewed AI memory demand call, plus a China angle: Trump’s Beijing trip includes Micron’s CEO on the business roster.
  • Bulls are pointing to constrained supply and surging HBM demand from AI. Bears, though, note the chart’s sharp runup—the semiconductor index now shows its most overbought signal since the dot-com era.

Micron Technology is catching a bid ahead of the bell, but it’s not a straightforward “good news, stock up” situation. Shares wrapped up Tuesday at $766.58, off 3.61%. In premarket, though, they’re changing hands at $812.06, up 5.93%—basically erasing yesterday’s drop and pushing MU close to where it peaked on Monday. StockAnalysis

The main driver: a quick rebound into memory stocks following Tuesday’s chip slide. Reuters reported Micron climbing 6.2% before the bell, leading Western Digital, Seagate, and SanDisk higher, as traders snapped up shares in a sector just off all-time peaks.

China’s role looms large in today’s numbers. Micron CEO Sanjay Mehrotra is set to join President Donald Trump on his visit to China, where Trump says he’ll urge Xi Jinping to “open up” China for U.S. business. Beijing has its own ask: it wants the U.S. to relax restrictions on sending chipmaking equipment and advanced semiconductors. Reuters

Prediction markets have thrown some momentum behind the policy trade, but stopped short of a sure bet. On Polymarket, odds for a U.S.-China tariff agreement by May 31 landed around 62% “Yes,” with a resolution hinging on either an official word or a solid, widely reported consensus. That’s giving chip stocks a bit of a risk-on push, though export-control worries still hang overhead. Polymarket

BofA Securities took its Micron target up to $950 from $500, sticking with a Buy. Their call: AI is fueling enough memory demand to keep it out in front of supply, and ramping up new output isn’t simple given expensive capital, packaging constraints, and power limits. Translation—don’t count on high prices bringing new supply to cool things off anytime soon.

Forget the morning headlines—Micron’s latest earnings call offers a clearer picture for the stock. Fiscal Q2 revenue hit $23.86 billion, nearly three times what the company pulled in a year ago. Looking ahead, Micron set its fiscal Q3 revenue target at $33.5 billion, expecting gross margin to land around 81%. (That’s what’s left after covering production costs.) “Memory has become a strategic asset for our customers,” CEO Mehrotra said. Micron Technology

Micron struck an uncommonly assertive note for a memory maker. The company pointed to AI demand driving DRAM and NAND data-center bit TAM past 50% of total industry TAM for the first time in 2026. It also flagged that HBM4 shipments have started for Nvidia’s Vera Rubin platform. HBM—high-bandwidth memory—refers to stacked DRAM built to keep AI processors fed with data at speed.

NAND is pulling its weight, too. Micron reported that data-center NAND revenue more than doubled from the prior quarter in fiscal Q2. Demand for NAND, the company said, is “significantly in excess” of supply going forward—AI databases, cache offload, and solid-state storage are providing the lift.

Bulls see a clear setup: AI servers require higher memory per box, not less, and as Nvidia and AMD ramp, that lifts demand for HBM and DDR. A more concentrated memory market—Samsung and SK Hynix still on top—lets Micron flex pricing muscle. Reuters points out Micron, the No. 3 memory producer, is also the only major U.S. player.

The bear argument looks at the same chart. From late March, the Philadelphia Semiconductor Index shot up 64%, with the S&P 500 up almost 17%. Reuters noted Micron and AMD each more than doubled over that stretch. Steve Edwards at Morgan Stanley Wealth Management described it as a “perfect mix” of technical and fundamental strength. That mix, he warned, can unwind just as quickly. Reuters

This isn’t just theoretical. Reuters flagged the SOX index’s weekly relative strength index at 85.5, marking the most overbought level since March 2000. That RSI figure—a momentum tool traders watch for signs of overheated buying—has rarely gone higher. Peter Tuz at Chase Investment Counsel didn’t mince words: in markets that go “parabolic,” it’s time to wonder if sentiment has gotten out of hand. Reuters

Capex doesn’t get much attention, but it’s a big risk. Micron is looking at more than $25 billion in factory and equipment spending for fiscal 2026, and another increase slated for fiscal 2027, mainly to drive HBM and DRAM production. The push is critical right now, yet in the memory business, those investments can tip into oversupply fast if AI appetite cools or buyers hit pause on orders.

What’s happening today isn’t just another bounce—it’s a test of nerve. Once shares push past $800, buyers are basically betting on tight supply, China exposure, and the argument that AI memory demand won’t swing like those old DRAM cycles. Drop below $800, and the signal shifts: big runs, even with the best story, don’t get absorbed overnight.

Stock Market Today

  • Top Undervalued TSX Stocks Offering Value Opportunities in May 2026
    May 13, 2026, 9:13 AM EDT. As geopolitical concerns persist, the TSX shows resilience with investors focusing on fundamentals over short-term oil price shifts. Ten Canadian stocks stand out as undervalued based on discounted cash flow estimates, including Topicus.com (TSXV:TOI) at a 42.2% discount and Timbercreek Financial (TSX:TF) at 46.7%. Almonty Industries (TSX:AII), a tungsten miner, trades 31.1% below fair value amid strong revenue growth projections, while apparel retailer Aritzia (TSX:ATZ) is 39% undervalued with earnings growing 21.7% annually. These selections highlight potential buying opportunities as companies outpace market averages and offer returns supported by operational improvements and expansion strategies.

Latest articles

Hot PPI Shock Hits Wall Street As Oil Inventory Test Looms

Hot PPI Shock Hits Wall Street As Oil Inventory Test Looms

13 May 2026
U.S. producer prices rose 1.4% in April, the largest monthly gain since March 2022, with the Producer Price Index up 6.0% year-over-year, the Bureau of Labor Statistics said Wednesday. Energy prices surged 7.8%, gasoline 15.6%. S&P 500 futures turned negative after the data. The American Petroleum Institute reported U.S. crude inventories fell by 2.2 million barrels last week.
Antelope Enterprise Stock Jumps Again as Bitcoin Gain and Buyback Put AEHL in Focus

Antelope Enterprise Stock Jumps Again as Bitcoin Gain and Buyback Put AEHL in Focus

13 May 2026
Antelope Enterprise Holdings shares jumped 47.55% to $2.11 Tuesday after a 135% surge Friday. The company reported $190,000 in gains from its Bitcoin “Genius Plan” and approved a $95,000 share buyback. A May 11 SEC filing showed Streeterville Capital and affiliates reported zero ownership of Antelope shares. Nearly 49.8 million shares traded Tuesday.
Sivers Semiconductors AB Stock Jumps as MSCI Add Meets Nasdaq Listing Push

Sivers Semiconductors AB Stock Jumps as MSCI Add Meets Nasdaq Listing Push

13 May 2026
Sivers Semiconductors shares surged 31.3% to 56.65 crowns after MSCI added the company to its Sweden small-cap index. Shareholders recently approved a private placement of 8.62 million shares at 14.50 crowns each, raising about 125 million crowns. Sivers is preparing accounts to U.S. standards as it considers a dual listing on Nasdaq New York. The company delayed its 2025 annual report to May 15.

Popular

SELLAS Stock Jumps After AML Trial Moves Two Events From Final Readout

SELLAS Stock Jumps After AML Trial Moves Two Events From Final Readout

13 May 2026
SELLAS Life Sciences said its pivotal REGAL leukemia trial has recorded 78 of 80 events needed for final analysis, triggering a rise in after-hours trading. The company reported a first-quarter net loss of $8.4 million but ended March with $107.1 million in cash. Research and development spending increased to $5.1 million. SELLAS expects its cash to fund operations for at least 12 months.
IREN Stock’s Nvidia Boost Now Faces a $2.6 Billion Reality Check
Previous Story

IREN Stock’s Nvidia Boost Now Faces a $2.6 Billion Reality Check

Oil Slips, but the Real Trade Is Still Hormuz Risk
Next Story

Oil Slips, but the Real Trade Is Still Hormuz Risk

Go toTop